Comparison of Conventional Dialysis and the Allient System

Status unconfirmed · Not applicable

Conditions studied: End Stage Renal Disease, Chronic Kidney Failure

In brief

The purpose of the study to determine whether the level of inflammation may be decreased, the lifespan of red blood cells increased and the clearance of waste products in the blood improved through the use of the Allient System as compared to conventional hemodialysis.

Key facts

Study ID

NCT00788905

Run by

Renal Research Institute

People needed

40

Starts

2008-11-01

Expected to finish

2014-01-01

Last updated by the study team

2013-03-29

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Maintenance in-center hemodialysis
• Age greater than or equal to 18 years
• Has been on hemodialysis for at least 4 months
• Uses a standard single-pass dialysis machine with a high-flux dialyzer

You may not qualify if…

• Hospitalization during the 8 weeks preceding enrollment
• Infection requiring antibiotic treatment during the 8 weeks preceding enrollment
• Central venous cather as dialysis access
• Uncontrollable blood coagulation anomalies
• Smokers
• Dialysis regimen other than 3 times weekly
• In ability to understand the English language and give informed consent for participation in the study

Where it is running

• Irving Place Dialysis Center — New York, New York, United States
• Upper Manhattan Dialysis Center — New York, New York, United States
• Yorkville Dialysis Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.